Carbohydrate Intolerance Questionnaire Study — Curves1  

Carbohydrate Intolerance Clinical Trial

Official title: Validation of Carbohydrate Intolerance Questionnaire

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the validity of using a carbohydrate intolerance questionnaire (CIQ) and/or other health markers as a means of predicting response to insulin sensitivity as determined by an oral glucose tolerance test (OGTT).

Clinical Trial Description

This study will utilize a carbohydrate intolerance questionnaire (CIQ). Responses to a CIQ will be correlated with diet inventories, baseline body composition and health assessments, a standard metabolic panel, fasting glucose and insulin levels, a homeostatic insulin resistance model (HOMA), a two hour oral glucose tolerance test (OGTT), and a carbohydrate sensitivity symptom questionnaire administered during the OGTT. ;

Related Conditions & MeSH terms

• Carbohydrate Intolerance
• Carbohydrate Metabolism, Inborn Errors
• Malabsorption Syndromes

• NCT number: NCT03138902
• Study type: Interventional
• Source: Texas A&M University
• Status: Completed
• Phase: N/A
• Start date: June 1, 2013
• Completion date: December 31, 2013